A Seven-Marker Signature and Clinical Outcome in Malignant Melanoma: A Large-Scale Tissue-Microarray Study with Two Independent Patient Cohorts | PLOS ONE
![SciELO - Brasil - Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma SciELO - Brasil - Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma](https://minio.scielo.br/documentstore/1678-4774/TvQRW5PSF7KzgcPwtzggfMp/a77905511b14e1f98c2bbca638ee763004d17a29.gif)
SciELO - Brasil - Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma
![Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Weinstein-table1_June2014.jpg)
Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance - ScienceDirect Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821006127-fx1.jpg)
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance - ScienceDirect
![Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy | PNAS Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy | PNAS](https://www.pnas.org/cms/10.1073/pnas.1719264115/asset/1743d4ce-667a-48c9-8d90-eb275af63b04/assets/graphic/pnas.1719264115fig01.jpeg)
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy | PNAS
![Cancers | Free Full-Text | Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis Cancers | Free Full-Text | Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis](https://pub.mdpi-res.com/cancers/cancers-11-00076/article_deploy/html/images/cancers-11-00076-g001a.png?1570935603)
Cancers | Free Full-Text | Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
![Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals](https://images.novusbio.com/fullsize2/Melanoma-Marker-(MART-1-+-Tyrosinase-+-gp100)-Antibody-(A103-+-T311-+-HMB45)-Flow-(Intracellular)-NBP2-34339-img0003.jpg)
Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals
![Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Weinstein-table4_June2014.jpg)
Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms - eBioMedicine Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms - eBioMedicine](https://www.thelancet.com/cms/attachment/b199ac38-2b6f-4820-a05c-5110449f817e/gr1_lrg.jpg)
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms - eBioMedicine
![Dermatopathology | Free Full-Text | Aberrant Expression of Immunohistochemical Markers in Malignant Melanoma: A Review Dermatopathology | Free Full-Text | Aberrant Expression of Immunohistochemical Markers in Malignant Melanoma: A Review](https://pub.mdpi-res.com/dermatopathology/dermatopathology-08-00040/article_deploy/html/images/dermatopathology-08-00040-g001.png?1627984389)
Dermatopathology | Free Full-Text | Aberrant Expression of Immunohistochemical Markers in Malignant Melanoma: A Review
![Frontiers | Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects Frontiers | Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects](https://www.frontiersin.org/files/Articles/642380/fmed-08-642380-HTML/image_m/fmed-08-642380-g001.jpg)
Frontiers | Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
Biomarkers in Malignant Melanoma: Recent Trends and Critical Perspective - Cutaneous Melanoma - NCBI Bookshelf
![Standard melanoma-associated markers do not identify the MM127 metastatic melanoma cell line | Scientific Reports Standard melanoma-associated markers do not identify the MM127 metastatic melanoma cell line | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep24569/MediaObjects/41598_2016_Article_BFsrep24569_Fig1_HTML.jpg)
Standard melanoma-associated markers do not identify the MM127 metastatic melanoma cell line | Scientific Reports
![Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy. Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.](https://i0.wp.com/globalmedicaldiscovery.com/wp-content/uploads/2014/12/Immune-Escape-Markers-in-Relation-to-Clinical-Outcome-of-Advanced-Melanoma-Patients-Following-Immunotherapy.jpg?fit=555%2C416&ssl=1)